Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

An obstacle to cancer cells

16.12.2005


The circulation of cancer cells through the blood vessels is often the cause of metastasis. These cancer cells contaminate normal cells and the pathology spreads throughout the body. Metastasis is the main risk in cancers. In order to prevent this process from occurring, a team from the Chemistry Faculty at the Donostia-San Sebastián campus of the University of the Basque Country (UPV-EHU) analysed the connections between cancer and normal cells.



Concretely, the UPV-EHU analysed the proteins that are involved in these connections. From amongst these proteins, they chose the ones that have a single active centre. If this centre is blocked, the cancer cell will not be able to adhere itself to a healthy cell and, thus, this path of spreading the disease is blocked.

The first thing to do is to analyse the structure of the proteins chosen. This task is undertaken using computers, given that the proteins are gigantic molecules. Once the structure is analysed and with the data for the active centre of the connection, the design of a new, small molecule to block this centre is initiated.


Diminutive in order to be stealthy

The new molecule must have very special characteristics, the main one being its size: so that our immunological system does not detect it, it has to be very small; if the new synthesised molecule is any bigger, our immunological system will detect and destroy it.

Also, this new diminutive molecule must adhere itself to the active centre of the protein and, in order to do this, it has to comply to a series of requirements, i.e. it must imitate the naturally-occurring molecule that connects to the active centre.

Using all these characteristics, a series of molecules - a family of new molecules - is designed and then synthesised. It has to be taken into account that these molecules have not been created previously and do not exist naturally and, consequently, it is not known if they are stable or not.

The final step is to verify that the new synthesised molecules carry out their job.

To block and to die

First of all, trials are carried out in vitro. Here the new molecules are analysed for their capacity to adhere to the protein and neutralise it. If a cancer cell is unable to unite with a healthy cell and contaminate it, it enters a programmed stage of death and self-destructs. Moreover, as a range of molecules has been designed and developed, it has to be known which give the best results and which are the most active.

The most active molecule in the in vitro trials have to demonstrate subsequently that they are also the most active in vivo, and often the results can vary. It is possible for another molecule from the same family to have better results in vivo; thus, it is vital to carry out these trials.

Once the series of trials are over, it can be decided to enhance the molecule’s efficacy or, if the results are very good, the process to convert it into medication can be initiated. But this is not the task of chemists; their job now is to follow another line of research to design more new molecules to combat other protein cancer cell connections.

Garazi Andonegi | alfa
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Gelaxka=1_1&hizk=I&Berri_Kod=838
http://www.elhuyar.com

More articles from Life Sciences:

nachricht Fish recognize their prey by electric colors
13.11.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht The dawn of a new era for genebanks - molecular characterisation of an entire genebank collection
13.11.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

The dawn of a new era for genebanks - molecular characterisation of an entire genebank collection

13.11.2018 | Life Sciences

Fish recognize their prey by electric colors

13.11.2018 | Life Sciences

Ultrasound Connects

13.11.2018 | Awards Funding

VideoLinks
Science & Research
Overview of more VideoLinks >>>